ΔΎΉΟΦ±²₯

Meeting Coverage

SNO

Society for NeuroOncology

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

Also from SNO: Encouraging early results with ATM pathway inhibition, sonodynamic therapy

SNO over a photo of George R. Brown Convention Center in Houston, TX.

Latest SNO Meeting Coverage

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

Abemaciclib active in previously treated meningioma, fails to impress in glioblastoma combination

November 26, 2024
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma

Significant impact on RFS with subtotal resection, and molecular analysis suggests hypoxic effect

November 25, 2024
Early Promise for PI3K Inhibitor in Brain Metastases

Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease

November 25, 2024
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up

Two-fold increase in PFS with postoperative ivosidenib holds up in placebo-controlled trial

November 24, 2024
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study

November 22, 2024